CNSP: CNS Pharmaceuticals, Inc. Stock

by  •  • Comments Off on CNSP: CNS Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.22
Enterprise Value ($M) 1.97
Book Value ($M) -4.43
Book Value / Share -0.42
Price / Book -0.50
NCAV ($M) -4.54
NCAV / Share -0.43
Price / NCAV -0.49

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -2.54
Return on Equity (ROE) -5.40

Liquidity (mrq)
Quick Ratio 0.26
Current Ratio 0.26

Balance Sheet (mrq) ($M)
Current Assets 1.59
Assets 1.70
Liabilities 6.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -18.87
Net Income -18.85

Cash Flow Statement (mra) ($M)
Cash From Operations -14.14
Cash from Investing -0.00
Cash from Financing 4.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 9.99 308.69
08-01 13G Priebe Waldemar 0.30

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C., 20549 FORM 10-K
2023-11-14 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 O
2023-08-14 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(
2023-05-15 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-10 25,983 270,898 9.59
2024-05-09 67,060 434,578 15.43
2024-05-08 119,087 628,162 18.96
2024-05-07 42,075 22,347 188.28
2024-05-06 22,505 11,083 203.06

(click for more detail)

Similar Companies
CLRB – Cellectar Biosciences, Inc. CLVR – Clever Leaves Holdings Inc.
CMPX – Compass Therapeutics, Inc. CNTX – Context Therapeutics Inc.
COCP – Cocrystal Pharma, Inc.


Financial data and stock pages provided by
Fintel.io